Methyl iodide → 3-(4-[2-(5-Methyl-2-phenyl-oxazol-4-yl)-ethoxy]-2-{[methyl-(2,2,2-trifluoro-acetyl)-amino]-methyl}-phenyl)-propionic acid tert-butyl ester
반응식
[C:1]([O:5][C:6](=[O:38])[CH2:7][CH2:8][C:9]1[CH:14]=[CH:13][C:12]([O:15][CH2:16][CH2:17][C:18]2[N:19]=[C:20]([C:24]3[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=3)[O:21][C:22]=2[CH3:23])=[CH:11][C:10]=1[CH2:30][NH:31][C:32](=[O:37])[C:33]([F:36])([F:35])[F:34])([CH3:4])([CH3:3])[CH3:2].[H-].[Na+].I[CH3:42]>CN(C=O)C>[C:1]([O:5][C:6](=[O:38])[CH2:7][CH2:8][C:9]1[CH:14]=[CH:13][C:12]([O:15][CH2:16][CH2:17][C:18]2[N:19]=[C:20]([C:24]3[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=3)[O:21][C:22]=2[CH3:23])=[CH:11][C:10]=1[CH2:30][N:31]([CH3:42])[C:32](=[O:37])[C:33]([F:34])([F:35])[F:36])([CH3:4])([CH3:2])[CH3:3]참가 물질
반응물 3
생성물 1
시약·촉매·용매 1
실험 절차
A solution of 3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-2-[(2,2,2-trifluoro-acetylamino)-methyl]-phenyl}-propionic acid tert-butyl ester (151 mg, 0.28 mmol) in dry DMF (10 mL) was cooled in an ice bath and treated with NaH (22 mg, 0.55 mmol, 60% oil dispersion). After the reaction mixture was stirred for 25 min, iodomethane (0.15 mL, 3.0 mmol) was added, and the reaction was allowed to warm to ambient temperature gradually. After 4 h, more iodomethane (0.10 mL, 2 mmol) was added. The mixture was stirred overnight and was partitioned between EtOAc and aqueous LiCl solution. The organic layer was washed with brine, dried (Na2SO4), and concentrated. The residue was purified by silica gel radial chromatography (CH2Cl2/EtOAc 100/0 to 95/5) to give the title compound (111 mg, 73%).
후처리
- waitAfter 4 h
- stirringThe mixture was stirred overnight
- customwas partitioned between EtOAc and aqueous LiCl solution
- washThe organic layer was washed with brine
- dry with materialdried (Na2SO4)
- concentrationconcentrated
- customThe residue was purified by silica gel radial chromatography (CH2Cl2/EtOAc 100/0 to 95/5)
출처 및 근거
- ORD 기록
- ord-ba34edbd06884609b7d09cacf9d65d65
- 출처 데이터셋
- uspto-grants-2007_10
- 특허 번호
- US07282501B2
반응 노트
불러오는 중…